INCOZEN THERAPEUTICS PVT LTD has a total of 59 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2010. It filed its patents most often in China, Australia and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are BAJER SHERING FARMA AKTSIENGEZ, ZHEJIANG DTRM BIOPHARMA CO LTD and BRIDGE PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 8 | |
#2 | Australia | 6 | |
#3 | United States | 6 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Republic of Korea | 5 | |
#6 | WIPO (World Intellectual Property Organization) | 5 | |
#7 | Israel | 4 | |
#8 | New Zealand | 4 | |
#9 | Canada | 3 | |
#10 | EAPO (Eurasian Patent Organization) | 3 | |
#11 | Japan | 3 | |
#12 | Serbia | 2 | |
#13 | Singapore | 2 | |
#14 | Brazil | 1 | |
#15 | Hong Kong | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Muthuppalaniappan Meyyappan | 30 |
#2 | Viswanadha Srikant | 30 |
#3 | Babu Govindarajulu | 18 |
#4 | Vakkalanka Swaroop Kumar V S | 17 |
#5 | Vakkalanka Swaroop Kumar | 16 |
#6 | Merikapudi Gayatri Swaroop | 12 |
#7 | Vakkalanka Swaroop K V S | 9 |
#8 | Bhavar Prashnant Kashinath | 9 |
#9 | Vakkalanka Swaroop K | 5 |
#10 | Swaroop Kumar Vakkalanka | 4 |
Publication | Filing date | Title |
---|---|---|
CN110464724A | The method for treating autoimmunity, breathing and/or inflammatory conditions by sucking N-oxide of roflumilast | |
KR20150138160A | Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide | |
NZ703111A | Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases | |
NZ603935A | Novel immunomodulator and anti inflammatory compounds | |
CN102812013A | Novel Kinase Modulators |